Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 12/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096902 | 0.83 | SLC6A4 (0.36) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL30096893 | 0.79 | SLC6A3 (0.40) | SLC6A4SLC6A3KDM1ARCOR1SLC6A2 | |
| SCHEMBL30096856 | 0.69 | KDM1A (0.46) | SLC6A4SLC6A3KDM1ARCOR1SLC6A2 | |
| SCHEMBL27219444 | 0.68 | SLC6A4 (0.34) | SLC6A4SLC6A3KDM1ARCOR1SLC6A2 | |
| SCHEMBL30096845 | 0.68 | GRIN1 (0.33) | SLC6A3KDM1ASLC6A2 | |
| SCHEMBL30096836 | 0.65 | MGAT2 (0.36) | SLC6A4 | |
| SCHEMBL27219436 | 0.64 | PDE2A (0.35) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL30850067 | 0.62 | SLC6A4 (0.31) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL24871286 | 0.61 | ACHE (0.44) | — | |
| SCHEMBL25620596 | 0.60 | TSHR (0.41) | SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | AFF1, AFF2, AFF4 | SLC6A4 1505/4885SLC6A3 548/4885KDM1A 3289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.